Assessment of tumor response to the vascular disrupting agents 5,6-dimethylxanthenone-4-acetic acid or combretastatin-A4-phosphate by intrinsic susceptibility magnetic resonance imaging.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples